FDA Inspection 1057809 — Bora Pharmaceuticals Inc.
The FDA completed an inspection of Bora Pharmaceuticals Inc. on Jun 21, 2018 in Maple Grove, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 21, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Maple Grove, MN (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)